Alejandro Martínez

668 total citations
8 papers, 246 citations indexed

About

Alejandro Martínez is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Alejandro Martínez has authored 8 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Alejandro Martínez's work include Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Alejandro Martínez is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Alejandro Martínez collaborates with scholars based in Spain, United States and Chile. Alejandro Martínez's co-authors include Ana Rovira, Joan Albanell, Françesc Solé, Lara Pijuán, Edurne Arriola, Murry W. Wynes, Raquel Longarón, Ana B. Galván, Israel Cañadas and Sérgio Serrano and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology and Molecular Cancer Research.

In The Last Decade

Alejandro Martínez

8 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Martínez Spain 6 153 113 74 56 42 8 246
Şener Cihan Türkiye 10 66 0.4× 145 1.3× 47 0.6× 29 0.5× 21 0.5× 40 247
Vanessa Pachón Spain 8 24 0.2× 173 1.5× 36 0.5× 50 0.9× 13 0.3× 19 242
G. Michetti Italy 10 292 1.9× 114 1.0× 7 0.1× 19 0.3× 18 0.4× 21 427
Priya Sriskandarajah United Kingdom 8 27 0.2× 45 0.4× 6 0.1× 43 0.8× 27 0.6× 19 156
Haining Fan China 7 81 0.5× 125 1.1× 63 0.9× 71 1.3× 2 0.0× 29 291
Yaron Gesthalter United States 9 178 1.2× 83 0.7× 33 0.4× 65 1.2× 4 0.1× 28 292
José Manuel López Vega Spain 6 41 0.3× 93 0.8× 30 0.4× 15 0.3× 9 0.2× 9 173
V. Filipazzi Italy 8 116 0.8× 139 1.2× 6 0.1× 24 0.4× 14 0.3× 19 195
Paola Bertocchi Italy 12 77 0.5× 188 1.7× 61 0.8× 33 0.6× 25 269

Countries citing papers authored by Alejandro Martínez

Since Specialization
Citations

This map shows the geographic impact of Alejandro Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Martínez more than expected).

Fields of papers citing papers by Alejandro Martínez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Martínez. The network helps show where Alejandro Martínez may publish in the future.

Co-authorship network of co-authors of Alejandro Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Martínez. A scholar is included among the top collaborators of Alejandro Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Martínez. Alejandro Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Rodríguez‐Vida, Alejo, Núria Juanpere, Oriol Arpí, et al.. (2019). Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models. Molecular Cancer Research. 17(9). 1931–1944. 27 indexed citations
2.
Romero, Ignacio, Ana Santaballa, Santiago González-Santiago, et al.. (2019). Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer. Anti-Cancer Drugs. 30(6). 628–635. 9 indexed citations
3.
Phan, Tin, et al.. (2018). Dynamics and implications of models for intermittent androgen suppression therapy. Mathematical Biosciences & Engineering. 16(1). 187–204. 10 indexed citations
4.
Garzón, Mónica, Sergi Villatoro, Cristina Teixidó, et al.. (2016). KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients. Translational Lung Cancer Research. 5(5). 511–516. 16 indexed citations
5.
Martínez, Alejandro, Oriol Arpí, Sílvia Menéndez, et al.. (2015). Targeting the PI3K/AKT/mTOR pathway with MLN0128 (mTORC1/2 inh) and MLN1117 (PI3K alpha inh) in bladder cancer: Rational for its testing in clinical trials.. Journal of Clinical Oncology. 33(7_suppl). 369–369. 1 indexed citations
6.
Montagut, Clara, Beatríz Bellosillo, Iria González, et al.. (2014). Evolution of heterogeneous mechanisms of acquired resistance to cetuximab-based therapy in colorectal cancer.. Journal of Clinical Oncology. 32(15_suppl). 3526–3526. 5 indexed citations
7.
Salido, Marta, Lara Pijuán, Luz Martínez‐Avilés, et al.. (2010). Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(1). 21–27. 129 indexed citations
8.
Barriga, Francisco, Mónica Varas, Francisco Sapunar, et al.. (1997). Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-Neutropenic cancer patients. Medical and Pediatric Oncology. 28(3). 196–200. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şener Cihan Breakdown of academic impact, for papers by Vanessa Pachón Breakdown of academic impact, for papers by G. Michetti Breakdown of academic impact, for papers by Priya Sriskandarajah Breakdown of academic impact, for papers by Haining Fan Breakdown of academic impact, for papers by Yaron Gesthalter Breakdown of academic impact, for papers by José Manuel López Vega Breakdown of academic impact, for papers by V. Filipazzi Breakdown of academic impact, for papers by Paola Bertocchi
Rankless by CCL
2026